Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review

OBJECTIVE: To better define the rare adverse event (AE) of diabetes mellitus associated with immune checkpoint inhibitors (ICIs). DESIGN AND METHODS: We report the case of a lung cancer patient with diabetic ketoacidosis (DKA) and autoimmune thyroiditis during pembrolizumab treatment. We provide a s...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Eur J Endocrinol
Main Authors: de Filette, Jeroen M K, Pen, Joeri J, Decoster, Lore, Vissers, Thomas, Bravenboer, Bert, Van der Auwera, Bart J, Gorus, Frans K, Roep, Bart O, Aspeslagh, Sandrine, Neyns, Bart, Velkeniers, Brigitte, Kharagjitsingh, Aan V
Formato: Artigo
Idioma:Inglês
Publicado: Bioscientifica Ltd 2019
Assuntos:
Clinical Study
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6709545/
https://ncbi.nlm.nih.gov/pubmed/31330498
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EJE-19-0291
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares